3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Smoldering Multiple Myeloma
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Darbepoetin alfa
2
piperine
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Whole-Body Irradiation
1
Urination
1
Therapeutics
1
Sucrose
1
Rituximab
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Mycophenolic Acid
1
Morphine
1
Methotrexate
1
Methadone
1
Metformin
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Fentanyl
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Early Intervention, Educational
1
Cyclosporine
1
Curcumin
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Monoclonal Gammopathy of Undetermined Significance
×
Urination
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts